Bright Green announces plans to launch a program to support as many as 170 universities for cannabis research in the United States as well as an extension of the Company’s EB-5 initiative to enable foreign students attending universities in the United States to access EB-5 visas
July 17, 2023 09:00 ET
|
Bright Green Corporation
The Company plans to foster relationships with learning institutes across the U.S. to enhance the application of scientific discipline to the field of medical and pharmaceutical cannabinoid therapies...
Bright Green Announces it has been added to the Russell 3000® Index following the Annual Reconstitution
June 23, 2023 09:00 ET
|
Bright Green Corporation
The Company views the development as an additional milestone building on its key strategic achievement in 2023 already including its historic DEA registration and confirmation of its EB-5 program. ...
Bright Green Announces Closing of $3.5 Million Private Placement
May 24, 2023 16:00 ET
|
Bright Green Corporation
GRANTS, N.M., May 24, 2023 (GLOBE NEWSWIRE) -- Bright Green Corporation (NASDAQ: BGXX) (“Bright Green” or “the Company”), one of the very few companies selected by the U.S. government to grow,...
Bright Green Announces First Quarter 2023 Financial Update and Milestone Progress
May 24, 2023 08:00 ET
|
Bright Green Corporation
Bright Green has achieved several key milestones throughout the Quarter significantly advancing progress against its strategic plan, including a historic DEA Federal Registration and License Approval....
Bright Green Announces Pricing of $3.5 Million Private Placement
May 22, 2023 08:00 ET
|
Bright Green Corporation
GRANTS, N.M., May 22, 2023 (GLOBE NEWSWIRE) -- Bright Green Corporation (NASDAQ: BGXX) (“Bright Green” or “the Company”), one of the very few companies selected by the U.S. government to grow,...
Bright Green Announces the Launch of Its EB-5 Website and Program Following the Historic Announcement of Its Federal Registration and License Approval from the U.S. Drug Enforcement Administration
May 03, 2023 09:20 ET
|
Bright Green Corporation
Bright Green, the first publicly traded company in the U.S. to be federally authorized to grow, manufacture and sell cannabis and cannabis-related products for research, pharmaceutical and medical...
Bright Green Announces Historic Federal Registration and License Approval from the U.S. Drug Enforcement Administration Confirming Bright Green as a Bulk Manufacturer of Cannabis
May 01, 2023 08:30 ET
|
Bright Green Corporation
Bright Green is now the first publicly traded company, and the largest, in the U.S. to be federally authorized to grow, manufacture and sell cannabis and cannabis-related products for research,...
Bright Green Announces Fourth Quarter 2022 Financial Update
April 18, 2023 08:30 ET
|
Bright Green Corporation
Continued investment to support long-term strategy and pathway for growth, including plans to fully acquire Alterola Biotech, appointment of Seamus McAuley as Chief Executive Officer and expansion of...
Bright Green Announces Decision to Complete Alterola Biotech Acquisition
April 04, 2023 08:30 ET
|
Bright Green Corporation
Bright Green to acquire remaining 75% of Alterola common stock Agreements and completion will be subject to customary conditions and regulatory and stockholder approvals Alterola will support...
Bright Green Responds to False Claims Made Against the Company
February 21, 2023 08:30 ET
|
Bright Green Corporation
Denies any association with John Fikany and Jerry Capussi and categorically refutes the insinuations made on behalf of these individuals Company requesting immediate retraction while reserving the...